The treatment of chronic ulcerative colitis with pituitary adrenocorticotrophic hormone (ACTH). a clinical study of 28 cases.

J. M. Elliott,E. Kiefer,L. M. Hurxthal
DOI: https://doi.org/10.1056/NEJM195108232450803
IF: 158.5
1951-08-23
New England Journal of Medicine
Abstract:THE use of adrenocortical steroids and the adrenocortical-stimulating hormone of the pituitary gland constitutes a distinctly new approach to the treatment of a number of diseases. It is obvious that the possibilities of this form of therapy as applied in chronic ulcerative colitis should be further explored, as only a few cases of this disease treated with ACTH have been reported.1 , 2 The rationale of adrenocortical stimulation as a therapeutic measure in the treatment of chronic ulcerative colitis may be divided into a group of clinical observations and the theoretical concepts that favor the indication that ACTH would be beneficially effective . . .
What problem does this paper attempt to address?